Immune response profiling of patients with spondyloarthritis reveals signalling networks mediating TNF-blocker function in vivo - Archive ouverte HAL Access content directly
Journal Articles Annals of the Rheumatic Diseases Year : 2020

Immune response profiling of patients with spondyloarthritis reveals signalling networks mediating TNF-blocker function in vivo

(1, 2, 3) , (4) , (1, 2) , (1, 2) , (1) , (5) , (1) , (1, 2) , (1, 2) , (4) , (1) , (6) , (7, 8) , (7, 8) , , (9, 10) , (9, 10, 11) , (12, 1) , (12, 13, 14) , (1) , (1)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Vincent Rouilly
  • Function : Author
Claire Leloup
Consortium The Milieu Interieur
  • Function : Author
  • PersonId : 980144

Abstract

Objectives Antitumour necrosis factor (TNF) therapy has revolutionised treatment of several chronic inflammatory diseases, including spondyloarthritis (SpA). However, TNF inhibitors (TNFi) are not effective in all patients and the biological basis for treatment failure remains unknown. We have analysed induced immune responses to define the mechanism of action of TNF blockers in SpA and to identify immunological correlates of responsiveness to TNFi. Methods Immune responses to microbial and pathwayspecific stimuli were analysed in peripheral blood samples from 80 patients with axial SpA before and after TNFi treatment, using highly standardised wholeblood stimulation assays. Cytokines and chemokines were measured in a Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory, and gene expression was monitored using nCounter assays. Results Anti-TNF therapy induced profound changes in patients' innate immune responses. TNFi action was selective, and had only minor effects on Th1/Th17 immunity. Modular transcriptional repertoire analysis identified prostaglandin E 2 synthesis and signalling, leucocyte recirculation, macrophage polarisation, dectin and interleukin (IL)-1 signalling, as well as the nuclear factor kappa B (NF-kB) transcription factor family as key pathways targeted by TNF blockers in vivo. Analysis of induced immune responses before treatment initiation revealed that expression of molecules associated with leucocyte adhesion and invasion, chemotaxis and IL-1 signalling are correlated with therapeutic responses to anti-TNF. Conclusions We show that TNFi target multiple immune cell pathways that cooperate to resolve inflammation. We propose that immune response profiling provides new insight into the biology of TNFblocker action in patients and can identify signalling pathways associated with therapeutic responses to biological therapies.
Fichier principal
Vignette du fichier
Immune response profiling of patients with spondyloarthritis reveals signalling networks mediating TNF-blocker function in vivo MenegattiFull_ARD2021.pdf (21.06 Mo) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

pasteur-03046847 , version 1 (01-06-2021)

Licence

Attribution - CC BY 4.0

Identifiers

Cite

Silvia Menegatti, Vincent Guillemot, Eleonora Latis, Hanane Yahia-Cherbal, Daniela Mittermüller, et al.. Immune response profiling of patients with spondyloarthritis reveals signalling networks mediating TNF-blocker function in vivo. Annals of the Rheumatic Diseases, 2020, annrheumdis-2020-218304, ⟨10.1136/annrheumdis-2020-218304⟩. ⟨pasteur-03046847⟩
236 View
42 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More